Cytek Biosciences Inc (CTKB) financials · rev $201.5M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Cytek Biosciences Inc (CTKB) rev $201.5M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $201.5M | $200.5M |
| Cost of Revenue | $97.0M | $89.3M |
| Gross Profit | $104.5M | $111.1M |
| Operating Income | -$40.4M | -$20.5M |
| Net Income | -$66.5M | -$6.02M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $461.5M | $499.5M |
| Current Assets | $392.0M | $396.4M |
| Cash & Equivalents | $90.9M | $98.7M |
| Inventory | $48.4M | $43.9M |
| PP&E | $18.0M | $18.0M |
| Total Liabilities | $119.8M | $103.8M |
| Current Liabilities | $77.8M | $67.7M |
| Shareholders' Equity | $341.7M | $395.7M |
| Retained Earnings | -$101.7M | -$35.2M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$4.69M | $25.4M |
| CapEx | $4.08M | $3.52M |
| Investing Cash Flow | $10.1M | -$83.0M |
| Financing Cash Flow | -$13.4M | -$15.8M |
| Net Change in Cash | -$7.89M | -$68.9M |
| Free Cash Flow | -$8.77M | $21.9M |
FAQ
What is CTKB P/E and revenue?
Cytek Biosciences Inc (CTKB) rev $201.5M.
What is CTKB revenue?
Cytek Biosciences Inc last cached revenue is $201.5M (FY2025).
Is CTKB profitable?
Cytek Biosciences Inc last cached net income is -$66.5M (FY2025).
What are CTKB total assets?
Cytek Biosciences Inc last cached total assets are $461.5M (FY2025).
What is CTKB free cash flow?
Cytek Biosciences Inc last cached free cash flow is -$8.77M (FY2025).
Not investment advice. Cached statements, not a live tape.